Phase I/II study of bortezomib, lenalidomide, and dexamethasone treatment for relapsed and refractory multiple myeloma
| Image |  |
|---|---|
| Description | scientific article published on 24 January 2020 |
| Author/s |
author: Toshihiro Miyamoto |
| Publication date | January 24, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |